30.73

1.25% -0.39

Pre-market: 30.61 -0.12 -0.39%

Tg Therapeutics Inc (TGTX)

Overview News Price History Option Chain Financials Why TGTX Down? Discussions Forecast Stock Split

Tg Therapeutics Inc stock is traded at $30.73, with a volume of 1.25M. It is down -1.25% in the last 24 hours and down -3.82% over the past month. TG Therapeutics Inc is a fully integrated, commercial-stage, biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell diseases. The company has received approval from the U.S. Food and Drug Administration (FDA) for BRIUMVI (ublituximab-xiiy) for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS). In addition, it is developing TG-1701 (BTK inhibitor), Azer-Cel (allogeneic CD19 CAR T), and TG-1801 (anti-CD47/CD19 bispecific mAb) for B-cell disorders, which are under Phase 1 trials. Geographically, the company generates a majority of its revenue selling BRIUMVI in the United States, with the rest coming from sales in other countries.

Previous Close:

$31.12

Open:

$31.21

24h Volume:

1.25M

Relative Volume:

0.70

Market Cap:

$4.88B

Revenue:

$264.79M

Net Income/Loss:

$-14.36M

P/E Ratio:

-279.36

EPS:

-0.11

Net Cash Flow:

$-28.11M

1W Performance:

-0.19%

1M Performance:

-3.82%

6M Performance:

-15.95%

1Y Performance:

-4.74%

1-Day Range:

$30.70

$31.37

1-Week Range:

$29.79

$31.45

52-Week Range:

$25.28

$46.48

Tg Therapeutics Inc Stock (TGTX) Company Profile

Name

Tg Therapeutics Inc

Sector

Healthcare (1132)

Industry

Biotechnology (632)

Phone

(212) 554-4484

Address

2 GANSEVOORT STREET, 9TH FLOOR, NEW YORK, NY

Employee

352

Twitter

@TGTherapeutics

Next Earnings Date

2025-03-03

Latest SEC Filings

TGTX's Discussions on Twitter

Compare TGTX with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
TGTX Tg Therapeutics Inc	30.73	4.94B	264.79M	-14.36M	-28.11M	-0.11
VRTX Vertex Pharmaceuticals Inc	459.21	116.79B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	785.17	81.91B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	398.70	53.87B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	845.95	52.46B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	176.77	37.48B	447.02M	-1.18B	-906.14M	-6.1812

Tg Therapeutics Inc Stock (TGTX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Oct-06-25	Resumed	H.C. Wainwright	Buy
Jul-10-25	Resumed	Goldman	Neutral
Oct-29-24	Initiated	TD Cowen	Buy
Aug-02-23	Upgrade	Goldman	Sell → Neutral
Jun-26-23	Resumed	Jefferies	Buy
May-20-22	Initiated	BofA Securities	Underperform
Feb-23-22	Reiterated	B. Riley Securities	Buy
Nov-15-21	Downgrade	Goldman	Neutral → Sell
Apr-20-21	Initiated	Goldman	Neutral
Apr-19-21	Reiterated	H.C. Wainwright	Buy
Sep-01-20	Initiated	JP Morgan	Overweight
Aug-11-20	Reiterated	H.C. Wainwright	Buy
Jun-05-20	Initiated	Evercore ISI	Outperform
Jan-17-20	Reiterated	H.C. Wainwright	Buy
Nov-27-19	Resumed	B. Riley FBR	Buy
Feb-06-19	Resumed	Jefferies	Buy
Sep-25-18	Downgrade	Raymond James	Strong Buy → Outperform
Mar-09-18	Reiterated	B. Riley FBR, Inc.	Buy
Dec-01-17	Resumed	B. Riley FBR, Inc.	Buy
Nov-14-17	Resumed	H.C. Wainwright	Buy
Apr-25-17	Initiated	Jefferies	Buy
Mar-06-17	Reiterated	FBR & Co.	Outperform
Oct-06-16	Resumed	Brean Capital	Buy
May-27-16	Initiated	SunTrust	Buy
Dec-01-15	Initiated	FBR Capital	Outperform
Sep-09-15	Initiated	Raymond James	Strong Buy
Aug-12-15	Resumed	H.C. Wainwright	Buy
Jun-19-15	Reiterated	Brean Capital	Buy
Dec-11-14	Reiterated	ROTH Capital	Buy
Dec-10-14	Reiterated	ROTH Capital	Buy

View All

Tg Therapeutics Inc Stock (TGTX) Latest News

Dec 23, 2025

Trading the Move, Not the Narrative: (TGTX) Edition - news.stocktradersdaily.com

Dec 23, 2025

Dec 20, 2025

Will TG Therapeutics Inc. stock remain a Wall Street favorite2025 Support & Resistance & Consistent Profit Trading Strategies - Улправда

Dec 20, 2025

Dec 19, 2025

Can TG Therapeutics Inc. stock surprise with earnings upsideQuarterly Earnings Report & Technical Pattern Based Signals - Улправда

Dec 19, 2025

Can TG Therapeutics Inc. stock sustain institutional interest2025 Market Overview & Short-Term Trading Alerts - DonanımHaber

Dec 19, 2025

Is the Options Market Predicting a Spike in TG Therapeutics Stock? - Zacks Investment Research

Dec 19, 2025

How buybacks impact TG Therapeutics Inc. stock valueTrade Risk Report & Free Risk Controlled Daily Trade Plans - Улправда

Dec 19, 2025

Dec 18, 2025

Can TG Therapeutics Inc. stock resist sector downturns2025 Earnings Surprises & Daily Profit Maximizing Tips - Улправда

Dec 18, 2025

Is TG Therapeutics Inc. (NKB2) stock expanding market penetration2025 Trade Ideas & AI Forecasted Entry and Exit Points - ulpravda.ru

Dec 18, 2025

Why TG Therapeutics Inc. stock is in analyst buy zoneJuly 2025 Summary & Expert-Curated Trade Recommendations - Улправда

Dec 18, 2025

Earnings Recap: Why TG Therapeutics Inc. stock is in analyst buy zoneJuly 2025 Snapshot & Risk Controlled Stock Alerts - Улправда

Dec 18, 2025

Will TG Therapeutics Inc. stock benefit from automationMarket Activity Report & Free Expert Verified Stock Movement Alerts - Улправда

Dec 18, 2025

Why TG Therapeutics Inc. stock remains on watchlistsJuly 2025 Highlights & Community Driven Trade Alerts - Улправда

Dec 18, 2025

Dec 15, 2025

TG Therapeutics (TGTX) Lags Q1 Earnings Estimates - sharewise.com

Dec 15, 2025

Dec 14, 2025

Marex Group plc Makes New $10.02 Million Investment in TG Therapeutics, Inc. $TGTX - MarketBeat

Dec 14, 2025

TG Therapeutics (NASDAQ:TGTX) Rating Increased to Buy at Wall Street Zen - MarketBeat

Dec 14, 2025

Dec 13, 2025

Eventide Asset Management LLC Increases Holdings in TG Therapeutics, Inc. $TGTX - MarketBeat

Dec 13, 2025

Dec 12, 2025

Is TG Therapeutics (TGTX) Quietly Reframing Its Investment Story Around Neurology Depth Over Breadth? - Sahm

Dec 06, 2025

1832 Asset Management L.P. Has $5.18 Million Stock Holdings in TG Therapeutics, Inc. $TGTX - MarketBeat

Dec 06, 2025

TG Therapeutics (NASDAQ:TGTX) Lowered to "Hold" Rating by Wall Street Zen - MarketBeat

Dec 06, 2025

Dec 05, 2025

Lacklustre Performance Is Driving TG Therapeutics, Inc.'s (NASDAQ:TGTX) Low P/S - 富途牛牛

Dec 05, 2025

Dec 04, 2025

New York State Common Retirement Fund Boosts Stake in TG Therapeutics, Inc. $TGTX - MarketBeat

Dec 04, 2025

Dec 03, 2025